A doctor has revealed six of the biggest mistakes people on weight loss drugs can make. Nobody's perfect, but when it comes ...

The pivot to FDA-approved generics as patents expire in various countries follows a year of soaring demand for the branded ...

Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.

President Trump urged pharmaceutical companies to publicly prove that their Covid-19 products work, saying in a Truth Social ...

Treatment with the anti-obesity medications can reduce health risks for patients with heart failure by more than 40%. These ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy growth stocks to buy now. On August 28, Teva ...

Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs ...

GoodRx reports that HSA and FSA can cover weight-loss expenses if prescribed for medical conditions, requiring a letter of ...

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the ...

The U.S. Food and Drug Administration has approved Teva Pharmaceuticals' cheaper generic version of Novo Nordisk's older weight-loss drug, Saxenda, the Israel-based company said on Thursday.

"With this approval, and by launching a generic for Saxenda (liraglutide injection), we will provide patients in the U.S. the first ever generic GLP-1 product specifically indicated for weight loss," ...

Advocates are pushing back against Tricare's plan to end its coverage of weight-loss drugs for Tricare for Life beneficiaries ...